Summary
The MTA1 gene is a recently identified novel candidate breast cancer metastasis-associated gene which has been implicated in the signal transduction or regulation of gene expression. We examined the mRNA expression levels of the MTA1, the human homologue of the rat mta1 gene in 47 surgically resected oesophageal squamous cell carcinomas by quantitative reverse transcription polymerase chain reaction. The relative overexpression of MTA1 mRNA (tumour/normal ratio ≥ 2) was observed in 16 out of 47 (34.0%) oesophageal carcinomas. Oesophageal tumours overexpressing MTA1 mRNA (T/N ratio ≥ 2) showed significantly higher frequencies of adventitial invasion (P < 0.05) and lymph node metastasis (P < 0.05), and tended to have a higher rate of lymphatic involvement than the remaining tumours. Thus, the data suggest that the MTA1 gene might play an important role in invasion and metastasis of oesophageal carcinomas.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bar-Sagi, D., Rotin, D., Batzer, A., Mandiyan, V. & Schlessinger, J. (1993). SH3 domains direct cellular localization of signaling molecules. Cell 74: 83–91.
Basset, P., Bellocq, J. P., Wolf, C., Stoll, I., Hutin, P., Limacher, J. M., Podhajcer, O. L., Chenard, M. P., Rio, M. C. & Chambon, P. (1990). A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699–704.
Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem 162: 156–159.
Dear, T. N., Ramshaw, I. A. & Kefford, R. F. (1988). Differential expression of a novel gene, WDNM1, in nonmetastatic rat mammary adenocarcinoma cells. Cancer Res 48: 5203–5209.
Dear, T. N., McDonald, D. A. & Kefford, R. F. (1989). Transcriptional down-regulation of a rat gene, WDNM2, in metastatic DMBA-8 cells. Cancer Res 49: 5323–5328.
Ebralidze, A., Tulchinsky, E., Grigorian, M., Afanasyeva, A., Senin, V., Revazova, E. & Lukanidin, E. (1989). Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca2+-binding protein family. Genes Develop 3: 1086–1093.
Hollstein, M. C., Metcalf, R. A., Welsh, J. A., Montesano, R. & Harris, C. C. (1990). Frequent mutation of the p53 gene in human oesophageal cancer. Proc Natl Acad Sci USA 87: 9958–9961.
Japanese Society for Oesophageal Disease (1976). Guidelines for the clinical and pathologic studies on carcinoma of the oesophagus. Jpn J Surg 6: 69–78.
Kadowaki, T., Shiozaki, H., Inoue, M., Tamura, S., Oka, H., Doki, Y., Iihara, K., Matsui, S., Iwazawa, T., Nagafuchi, A., Tsukita, S. & Mori, T. (1994). E-cadherin and alpha-catenin expression in human oesophageal cancer. Cancer Res 54: 291–296.
Liotta, L. A., Steeg, P. S. & Stetler-Stevenson, W. G. (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327–336.
Lu, S. H., Hsieh, L. L., Luo, F. C. & Weinstein, I. B. (1988). Amplification of the EGF receptor and c-myc genes in human oesophageal cancers. Int J Cancer 42: 502–505.
Nakagawa, H., Zukerberg, L., Togawa, K., Meltzer, S. J., Nishihara, T. & Rustgi, A. K. (1995). Human cyclin D1 oncogene and oesophageal squamous cell carcinoma. Cancer 76: 541–549.
Nicolson, G. L. (1988). Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta 948: 175–224.
Paterno, G. D., Yu, L., Luchman, H. A., Ryan, P. J. & Gillespie, L. L. (1997). cDNA cloning of a novel, developmentally regulated immediate early gene activated by fibroblast growth factor and encoding a nuclear protein. J Biol Chem 272: 22591–25595.
Pawson, T. & Gish, G. D. (1992). SH2 and SH3 domains: from structure to function. Cell 71: 359–362.
Pencil, S. D., Toh, Y. & Nicolson, G. L. (1993). Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma. Breast Cancer Res Treat 25: 165–174.
Phillips, S. M., Bendall, A. J. & Ramshaw, I. A. (1990). Isolation of gene associated with high metastatic potential in rat mammary adenocarcinomas. J Natl Cancer Inst 82: 199–203.
Ren, R., Mayer, B. J., Cicchetti, P. & Baltimore, D. (1993). Identification of a ten-amino-acid proline-rich SH3 binding site. Science 259: 1157–1161.
Seidel-Dugan, C., Meyer, B. E., Thomas, S. M. & Brugge, J. S. (1992). Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src. Mol Cell Biol 12: 1835–1845.
Shima, I., Sasaguri, Y., Kusukawa, J., Yamana, H., Fujuta, H., Kakegawa, T. & Morimatsu, M. (1992). Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer 70: 2747–2753.
Steeg, P. S., Bevilacqua, G., Kopper, L., Thorgeirsson, U. P., Talmadge, J. E., Liotta, L. A. & Sobel, M. E. (1988). Evidence for a novel gene associated with low tumor metastatic potential. J Natal Cancer Inst 80: 200–204.
Sugimachi, K., Matsuoka, H., Ohno, S., Mori, M. & Kuwano, H. (1988). Multivariate approach for assessing the prognosis of clinical oesophageal carcinoma. Br J Surg 75: 1115–1118.
Sugimachi, K., Watanabe, M., Sadanaga, N., Ikebe, M., Kitamura, K., Mori, M. & Kuwano, H. (1994). Recent advances in the diagnosis and surgical treatment of patients with carcinoma of the oesophagus. J Am Coll Surg 178: 363–368.
Taniguchi, S., Miyamoto, S., Sadano, H. & Kobayashi, H. (1992). Rat elongation factor 1 alpha: sequence of cDNA from a highly metastatic fos-transferred cell line. Nucleic Acids Res 19: 6949
Toh, Y., Pencil, S. D. & Nicolson, G. L. (1994). A novel candidate metastasis-associated gene, mtal, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem 269: 22958–22963.
Toh, Y., Pencil, S. D. & Nicolson, G. L. (1995). Analysis of the complete sequence of the novel metastasis-associated candidate gene, mta1, differentially expressed in mammary adenocarcinoma and breast cancer cell lines. Gene 159: 97–104.
Toh, Y., Oki, E., Oda, S., Tokunaga, E., Ohno, S., Maehara, Y., Nicolson, G. L. & Sugimachi, K. (1997). Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer 74: 459–463.
Yu, H., Chen, J. K., Feng, S., Dalgarno, D. C., Brauer, A. W. & Schreiber, S. L. (1994). Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76: 933–945.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Toh, Y., Kuwano, H., Mori, M. et al. Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. Br J Cancer 79, 1723–1726 (1999). https://doi.org/10.1038/sj.bjc.6690274
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690274
Keywords
This article is cited by
-
MTA1 as negative prognostic marker in vulvar carcinoma
Journal of Cancer Research and Clinical Oncology (2023)
-
Correlation of two distinct metastasis-associated proteins, MTA1 and S100A4, in angiogenesis for promoting tumor growth
Oncogene (2019)
-
Epigenomic regulation of oncogenesis by chromatin remodeling
Oncogene (2016)
-
Ras induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity
BMC Cancer (2015)
-
MTA1—a stress response protein: a master regulator of gene expression and cancer cell behavior
Cancer and Metastasis Reviews (2014)